Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listValspodar

Valspodar

Synonym(s):[3′-Desoxy-3′-oxo-MeBmt]1-[Val]2-cyclosporin;6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic acid]cyclosporin D;Amdray;PSC833

  • CAS NO.:121584-18-7
  • Empirical Formula: C63H111N11O12
  • Molecular Weight: 1214.62
  • MDL number: MFCD00907207
  • EINECS: 1312995-182-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-10-28 23:16:16
Valspodar Structural

What is Valspodar?

Description

PSC 833 is a non-immunosuppressant derivative of cyclosporine and potent multidrug-resistance (MDR) modulator. It restores sensitivity of MDR-P388 murine leukemia cells to cytostatic agents when used at concentrations of 70, 33, 45, 34, and 26 nM in combination with colchicine, vincristine , daunorubicin , doxorubicin , and etoposide , respectively. PSC 833 inhibits basal-to-apical transport and increases apical-to-basal transport of [14C]docetaxel in LLC-GA5-COLO150 cells that overexpress human P-glycoprotein (P-gp). In vivo, PSC 833 increases survival time in MDR-P388 tumor-bearing mice and in an MDR-L1210 leukemia mouse xenograft model when administered in combination with doxorubicin. PSC 833 also prolongs the anti-hyperalgesic effects of intraperitoneally administered pregabalin in a mouse model of cold stress-induced central pain.

Chemical properties

White Solid

The Uses of Valspodar

Valspodar/ PSC-833 has been used as a ABCB1 (P-glycoprotein) inhibitor.

The Uses of Valspodar

Antineoplastic adjunct (chemosensitizer).

The Uses of Valspodar

Valspodar(PSC-833), a 2nd-generation ABC transporter inhibitor, limits HCMV infection as demonstrated by the decrease in IE2 expression of virus-infected cells. As a cyclosporin D analog, it has been shown to be a much more effective inhibitor of MDR than cyclosporin A and to be less toxic[1-2].

What are the applications of Application

PSC 833 is a P-glycoprotein (P-gp, Mdr-1) modulator shown to inhibit P-gp-mediated multidrug-resistance (MDR).

Definition

ChEBI: SDZ PSC 833 is a homodetic cyclic peptide.

brand name

Amdray (Novartis).

Biochem/physiol Actions

Valspodar is a nonimmunosuppressive cyclosporin analog and potent P-glycoprotein (MDR1) inhibitor. Valspodar reverses multidrug resistance (MDR) by inhibiting cellular drug efflux mediated by P-glycoprotein.

Cytotoxicity

Cells treated with increasing concentrations of valspodar over a 9-day period show minimal cytotoxicity. It appears to be neither immunosuppressive nor nephrotoxic with the ability to achieve levels in the blood (1 μm) capable of reversing drug resistance without excessive toxicity[1].

storage

Store at -20°C

References

[1] Friedenberg W, et al. Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95). Cancer, 2006; 106: 830-838.
[2] Parsons J, et al. Valspodar limits human cytomegalovirus infection and dissemination. Antiviral Research, 2021; 193: 105124.

Properties of Valspodar

Melting point: 143-145°C
alpha  D20 -255.1° (c = 0.5 in CHCl3)
Boiling point: 1290.1±65.0 °C(Predicted)
Density  1.015±0.06 g/cm3(Predicted)
storage temp.  -20°C
solubility  Chloroform (Slightly), Methanol (Slightly)
pka 12.45±0.70(Predicted)
form  powder
color  white to beige

Safety information for Valspodar

Computed Descriptors for Valspodar

InChIKey YJDYDFNKCBANTM-QCWCSKBGSA-N

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.